Patrick Lu
Vorstandsvorsitzender bei SIRNAOMICS LTD.
Vermögen: 8 Mio $ am 30.04.2024
Profil
Yang Lu is the founder of Intradigm Corp.
(founded in 2001), Sirnaomics, Inc. (founded in 2007), Guangzhou Natai Biomedical Technology Co., Ltd.
(founded in 2012), Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
(founded in 2008), and Sirnaomics Ltd.
(founded in 2020).
Dr. Lu held various titles at the companies he founded, including President & Chief Executive Officer, Chairman, and President & Chief Executive Officer.
Dr. Lu received his undergraduate, graduate, and doctorate degrees from Sun Yat-Sen University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SIRNAOMICS LTD.
10,60% | 07.03.2024 | 9 289 082 ( 10,60% ) | 8 Mio $ | 30.04.2024 |
Aktive Positionen von Patrick Lu
| Unternehmen | Position | Beginn |
|---|---|---|
| SIRNAOMICS LTD. | Vorstandsvorsitzender | 15.10.2020 |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Vorstandsvorsitzender | 01.01.2007 |
Guangzhou Natai Biomedical Technology Co., Ltd.
 Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a private company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | Gründer | 08.05.2012 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Vorstandsvorsitzender | 10.03.2008 |
Ehemalige bekannte Positionen von Patrick Lu
| Unternehmen | Position | Ende |
|---|---|---|
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Gründer | 01.01.2007 |
Ausbildung von Patrick Lu
| Sun Yat-Sen University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIRNAOMICS LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Guangzhou Natai Biomedical Technology Co., Ltd.
Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a private company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | Health Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
